bacteriostatic antibacterial drug for the treatment of infections caused by lincomycin-sensitive microorganisms


Active ingredient (INN)
Composition (active ingredients)
lincomycin hydrochloride monohydrate - 340.2 mg, in terms of lincomycin - 300.0 mg
Фармакотерапевтическая группа
antibiotic lincosamide
Pharmacotherapeutic group
solution for infusion and intramuscular injection of 300 mg / ml 1 ml No.10
Сonditions of supply
on prescroption


Bacterial infections caused by lincomycin-sensitive microorganisms (especially Staphylococcus spp. And Streptococcus spp., Especially penicillin-resistant microorganisms, as well as with penicillin allergy):
  • sepsis;
  • subacute septic endocarditis;
  • lung abscess
  • pleural epilema;
  • pleurisy;
  • otitis;
  • osteomyelitis (acute and chronic);
  • purulent arthritis;
  • postoperative purulent complications;
  • wound infection;
  • infections of the skin and soft tissues (pyoderma, furunculosis, phlegmon, erysipelas).
Dosage regimen

Dosage regimen

Intravenously and intramuscularly.

For adults with intravenous and intramuscular administration

daily dose - 1,8 g; single dose - 0,6 g; the drug is administered 3 times a day at intervals of 8 hours

In severe infections

daily dose may be increased to 2,4 g

Children older than 1 month.

intravenously in a daily dose of 10 to 20 mg/kg, regardless of age, the duration of treatment, depending on the form and severity of the disease, is 7-14 days (for osteomyelitis - 3 weeks or more)

Patients with renal hepatic impairment

lincomycin is prescribed for intravenous and intramuscular administration in a daily dose not exceeding 1,8 g, with an interval between administrations of at least 12 hours


There are contraindications, consult with a specialist before use

Other products in this category